2013 | 2014 | 2015 | 2016 | ||||||||||||
Q1 | Q2 | Q3 | Q4 | Q1 | Q2 | Q3 | Q4 | Q1 | Q2 | Q3 | Q4 | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Clinical data and questionnaires | |||||||||||||||
SPIROMICS enrolment (n=2982) | |||||||||||||||
Visit 2 (n=2350) | |||||||||||||||
Visit 3 (n=1492) | |||||||||||||||
Visit 4 (n=894) | |||||||||||||||
HIQ administered (n=1938)* | |||||||||||||||
Environmental monitoring | |||||||||||||||
Baltimore | |||||||||||||||
LA | |||||||||||||||
SLC | SLC | ||||||||||||||
SF | SF | ||||||||||||||
NYC | |||||||||||||||
AA | AA | ||||||||||||||
W-S |
Sites: AA (Ann Arbor, Michigan); LA (Los Angeles, California); NYC (New York City, New York); SF (San Francisco, California); SLC (Salt Lake City, Utah); W-S (Winston-Salem, North Carolina).
*HIQ administered once to each participant by in-person or telephone interview. 1936 is the total number administered as of 1 September 2016.
HIQ, Home Information Questionnaire; SPIROMICS, Subpopulations and Intermediate Outcome Measures in COPD Study.